UNICEF TRVST system

One Year of TRVST Connectivity: What Operational Readiness Really Means

One Year of TRVST Connectivity: What Operational Readiness Really Means

 

Counterfeit and falsified medicines are not a theoretical risk.

According to UNICEF and the World Health Organization, counterfeit and falsified medicines are estimated to cause the death of 169,000 children under the age of five every year, driven by a counterfeit medicines market worth more than US$30 billion annually in low- and middle-income countries.

In response to this global challenge, UNICEF and its partners developed the Traceability and Verification System (TRVST) — a digital platform designed to help countries verify the authenticity of medicines and track them through the supply chain.

But while TRVST is gaining visibility, an important operational question remains for pharmaceutical manufacturers:

What does it actually mean to be connected to TRVST — and ready to use it in practice?

At SoftGroup, our interface to TRVST has been established and operational for over a year, with customers already providing data through it. This experience offers a practical view into what TRVST readiness really involves.

Why TRVST Exists: A Global Patient Safety Challenge

 

TRVST was launched in 2022 under UNICEF’s Verification and Traceability Initiative (VTI) — a multi-stakeholder partnership including organizations such as the Bill & Melinda Gates Foundation, the European Commission, Gavi, the Global Fund, USAID, the World Bank, and national regulatory authorities.

Its purpose is clear:
to strengthen countries’ ability to detect counterfeit and falsified medicines by enabling real-time verification and traceability on a single, shared platform.

UNICEF estimates that one in ten medical products in low- and middle-income countries may be counterfeit or falsified — a risk that increases during periods of high demand, such as the COVID-19 vaccine rollout.

Beyond treatment failure, falsified medicines can cause direct harm, including poisoning, and undermine trust in health systems and immunization programs.

 

 

How TRVST Works (and Why Standards Matter)

 

TRVST relies on a global repository that stores critical product information, including:
  • Global Trade Item Numbers (GTINs)
  • Serial numbers
  • Batch and lot data
  • Production and expiry dates
Manufacturers feed this data into TRVST, and authorized users — such as healthcare workers, regulators, and customs authorities — can verify product authenticity by scanning GS1-compliant barcodes using a mobile application.
Any verification failure or suspicious activity triggers alerts to both manufacturers and regulatory authorities.
Importantly, TRVST is designed to:
  • Use GS1 global standards
  • Integrate with national information systems
  • Support countries on their journey toward end-to-end traceability

 

What It Means to Have an Interface to TRVST

 

Having an interface to TRVST means that an IT system is technically capable of exchanging serialized product and event data with the TRVST platform via its published API specifications.
This includes the ability to:
  • Structure data according to GS1 standards
  • Transmit serialization and product events securely
  • Support verification and traceability workflows
Interfaces are tested and approved at a technical level to ensure correct data exchange.
This approval applies only to the interface itself, not to the IT provider or its software solution.

 

SoftGroup’s Experience: One Year of Operational Connectivity

 

SoftGroup established its interface to TRVST over a year ago. Since then, the connection has been used in operational environments, supporting customers that already provide data to TRVST.
This practical experience highlights a key reality:
TRVST connectivity is not a single technical milestone — it is an ongoing operational commitment.
Through live usage, we have seen that successful TRVST participation depends on:
  • Serialization maturity
  • High-quality, structured master data
  • Clear operational ownership
  • Scalable reporting and monitoring processes
These requirements become visible only when systems move from “connected” to actively used.

 

Why Readiness Matters as TRVST Expands

 

RVST continues to expand in scope and adoption.
As of November 2025 (UNICEF data):
  • TRVST stores information for over 80% of vaccines procured by UNICEF
  • Covers 200 products and more than 30 million serialized packs
  • Is used in nine countries, including Nigeria, Rwanda, Nepal, Botswana, Liberia, Senegal, Zimbabwe, Uganda, and Togo
  • Is expanding beyond COVID-19 vaccines to include childhood vaccines, HIV, tuberculosis, reproductive health supplies, and essential medicines
  • Oncology and antimalarial products are planned for inclusion in 2026
As participation grows, the ability to sustain data quality, interoperability, and operational discipline becomes critical.

 

UNICEF does not endorse any specific IT solution or provider. TRVST is open to any IT solution provider connecting via its published API specifications. SoftGroup’s interface refers solely to the technical capability to exchange data with the TRVST platform.

 

Preparing for TRVST or similar national traceability systems?

 

Talk to SoftGroup about operational readiness, data quality, and scalable compliance.